监督运动治疗对间歇性跛行可改变心血管危险因素影响的系统综述与荟萃分析
短期监督运动治疗使收缩压降低4 mmHg、舒张压降低2 mmHg;中期使低密度脂蛋白胆固醇和总胆固醇各降低0.2 mmol/L,对心率、甘油三酯、血糖等无显著影响。
要点
- 监督运动治疗短期可降低收缩压4 mmHg和舒张压2 mmHg。
- 中期可降低低密度脂蛋白胆固醇和总胆固醇各0.2 mmol/L。
- 对心率、甘油三酯、血糖、体重、吸烟等无显著改善。
核心结论
- 监督运动治疗对间歇性跛行患者血压和胆固醇水平有有利影响,支持将其用于危险因素修正。
研究设计与样本
- 纳入标准为报告至少一种指定心血管危险因素的基线和随访值。
- 采用随机效应模型分析随访与基线间的合并均数差,分短期(6周-3个月)和中期(6-12个月)结果。
主要发现
- 短期监督运动治疗使收缩压降低4 mmHg(10项研究;95%CI -6.40至-1.76;I2=0%)。
- 短期监督运动治疗使舒张压降低2 mmHg(8项研究;95%CI -3.64至-0.22;I2=35%)。
- 中期监督运动治疗使低密度脂蛋白胆固醇降低0.2 mmol/L(4项研究;95%CI -0.30至-0.12;I2=29%)。
- 中期监督运动治疗使总胆固醇降低0.2 mmol/L(4项研究;95%CI -0.38至-0.10;I2=36%)。
- 对心率、甘油三酯、高密度脂蛋白胆固醇、血糖、糖化血红蛋白、体重、体重指数或吸烟无显著影响。
临床怎么用
- 可将监督运动治疗作为间歇性跛行患者改善血压和胆固醇的辅助措施,而不仅用于增加步行距离。
局限性
- 证据质量中等,单项试验样本量较小,且研究间存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular events, such as myocardial infarction and stroke, contribute significantly to the prognosis of patients with peripheral artery disease. Therefore cardiovascular risk reduction is a vital element of treatment in patients with intermittent claudication (IC). The cardiovascular risk is largely determined by modifiable risk factors, which can be treated with medical care and lifestyle adjustments, such as increasing physical activity. The objective of this study was to determine the effects of supervised exercise therapy (SET) on modifiable cardiovascular risk factors in IC patients. METHODS: This is a systematic review and meta-analysis of prospective studies on the effects of SET on cardiovascular risk factors in symptomatic IC patients. Studies were eligible if they presented baseline and follow-up values for at least one of the following risk factors: blood pressure (systolic or diastolic), heart rate, lipid profile (total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol), glucose, glycated hemoglobin, body weight, body mass index, or cigarette smoking. Pooled mean differences between follow-up and baseline were analyzed using a random-effects model. Data were classified into short-term results (6 weeks-3 months) and midterm results (6-12 months). Statistical heterogeneity was presented as I2 and Q statistic. RESULTS: Twenty-seven studies with a total of 808 patients were included in this review. In the short term, SET resulted in significant improvements of systolic blood pressure (decrease of 4 mm Hg; 10 studies; 95% confidence interval [CI], -6.40 to -1.76; I2, 0%) and diastolic blood pressure (decrease of 2 mm Hg; 8 studies; 95% CI, -3.64 to -0.22; I2, 35%). In the midterm, SET contributed to significant lowering of levels of low-density lipoprotein cholesterol (decrease of 0.2 mmol/L; four studies; 95% CI, -0.30 to -0.12; I2, 29%) and total cholesterol (decrease of 0.2 mmol/L, four studies; 95% CI, -0.38 to -0.10; I2, 36%). No significant effects of SET were identified for heart rate, triglycerides, high-density lipoprotein cholesterol, glucose, glycated hemoglobin, body weight, body mass index, or cigarette smoking. CONCLUSIONS: This systematic review and meta-analysis shows favorable effects of SET on modifiable cardiovascular risk factors, specifically blood pressure and cholesterol levels. Despite the moderate quality, small trial sample sizes, and study heterogeneity, these findings support the prescription of SET programs not only to increase walking distances but also for risk factor modification. Future studies should address the potential effectiveness of SET to promote a healthier lifestyle and to improve cardiovascular outcomes in patients with claudication.
引用
- Jansen SCP, Hoorweg BBN, Hoeks SE, et al. A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittent claudication. J Vasc Surg. 2019. PMID: 30777692. doi:10.1016/j.jvs.2018.10.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。